Comparison on the prevention of severe influenza between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database -2018/2019 influenza season
Not Applicable
- Conditions
- Influenza virus infection
- Registration Number
- JPRN-UMIN000038159
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
please refer described below: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa1870/6044623
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 339007
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who were hospitalized on Day 1 or in the last 90 days before Day 1 2)Patients who received antibiotics on Day 1 or in the last 90 days before Day 1 3)Patients who were diagnosed as pneumonia in the last 3 months before Day 1 4)Patients who died on Day 1 5)Patients who were less than 1 year old on Day 1 6)Patients who received several anti-influenza drugs on Day 1
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of hospitalization
- Secondary Outcome Measures
Name Time Method Occurrence of administration of antibiotics, occurrence of pneumonia, occurrence of additional administration of anti-influenza drugs